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ABSTRACT 
Objective: Acetaminophen (APAP) overdose contributes to liver damage through modulation of pro-apoptotic processing. This study evaluated the 
involvement of caspase/Bax factors in APAP hepatotoxicity in vivo and in vitro. 
Methods: The involvement of caspase/Bax factors in APAP hepatotoxicity was evaluated in BALB/c mice and on isolated primary mouse 
hepatocytes. In vitro MTT assay was carried out on primary cultured mouse hepatocytes treated with APAP (2.5, 5, 10 mmol) and Annexin V/PI 
staining was employed to cell suspension for imaging under fluorescence microscopy. In addition, caspase-3 concentrations were determined in cell 
lysates. In vivo, mice were treated with a toxic dose of APAP (700 mg/kg) and immunodetection of Bax was made by Western Blot. Vitamin C (Vit C) 
was used as a hepato-protectant due to its known antioxidant activities.  
Results: In vitro dose-dependent increase in mitochondrial electron transport capacity was evident in isolated mouse primary hepatocytes 
incubated with the high dose of APAP (10 mmol) compared to both nontreated cells and cells pre-treated with Vitamin C (Vit C) (0.5 mmol) 
(p<0.05). Apoptosis was confirmed in hepatocytes through Annexin V staining after APAP treatment and the signal was reduced when hepatocytes 
were pre-treated with Vit C. In addition, caspase-3 concentration was decreased in cells pretreated with Vit C prior to APAP exposure. In vivo, Bax 
immunodetection utilizing western blotting was increased in mice treated with the toxic dose of APAP (700 mg/kg) and attenuated through pre-
treatment with Vit C.  
Conclusion: Modulation of apoptotic caspase/Bax pathway is present in hepatocytes undergoing APAP-induced toxicity. 
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INTRODUCTION 
The exact mechanism of toxicity behind Acetaminophen (APAP, also 
known as N-acetyl-para-aminophenol or paracetamol) is not fully 
elucidated despite its popular worldwide use as a safe and effective 
analgesic and antipyretic at therapeutic doses. Around 25% of 
administered APAP dose undergoes the first-pass metabolism 
primarily by conjugation with glucuronic acid and sulphate, 
thereafter, directly excreted in the urine [1]. Overdosing with APAP 
results in a fully saturated conjugative pathway shifting APAP 
metabolism into the cytochrome P450 (CYP450) pathway, therefore, 
leading to increased production of the toxic metabolite, namely, N-
acetyl-p-benzoquinone imine (NAPQI), which reduces glutathione 
(GSH) levels until depleted allowing disruptive binding to 
mitochondrial proteins [2]. It has been widely reported that NAPQI-
protein adduct formation leads to mitochondrial oxidative stress 
that generates superoxide anion O2-and other reactive oxygen 
species (ROS) and nitrogen-oxygen species (NOS) [3]. However, 
before NAPQI manages to induce cell death, initial mitochondrial 
metabolic activation has been reported to be critical as it needs to be 
amplified and propagated in order to initiate the cellular injury [4]. 
Since apoptosis is carefully programmed and balanced in a 
physiological context, the failure of this regulation results in critical 
pathological conditions [5]. In apoptosis, the integrity of 
mitochondrial architecture is lost causing depletion of ATP and 
translocation of Bax, a pro-apoptotic Bcl-2 protein, from the cytosol 
to the mitochondrion that causes pore formation in the outer 
mitochondrial membrane. This, in turn, releases pro-apoptotic 
cytochrome c from the mitochondrial intermembrane space and 
activates effector caspase-3 [6]. Moreover, once the cell undergoes 
apoptosis, an inner leaflet restricted lipid component called 
phosphatidylserine (PS) is translocated to the outer membrane 
scrambling the plasma membrane lipid asymmetry, thus, indicating 
apoptosis [7]. 
Since the toxicity of APAP has been widely described as dose-
dependent and several stages might be involved in its toxicity, the 
aim of the present study was to investigate the involvement of 
caspase/Bax pathway as a possible mechanism engaged in the 
activation of liver apoptosis during APAP hepatotoxicity. In addition, 
the extent of tackling APAP-induced caspase/Bax pathway activation 
by vitamin C (Vit C); as an efficient antioxidant known for its ROS 
scavenging and hepatoprotective effects, was approached [8]. 
MATERIALS AND METHODS 
Materials 
Acetaminophen (APAP), sodium chloride (NaCl), hydrochloric acid (HCl), 
L-ascorbic acid, and Dulbecco’s Modified Eagle Media (DMEM) (with L-
glutamine) were purchased from Sigma Aldrich (St. Louis, Missouri, 
USA). Isoflurane was supplied from Hikma Pharmaceuticals (Amman, 
Jordan). Hank's Balanced Salt Solution (HBSS) Ca2+ and Mg2+free, HBSS 
with Ca2+ and Mg2+ and collagenase II were purchased from Gibco 
(Gaithersburg, MD, USA). Fetal bovine serum (FBS), and trypsin were 
both obtained from Biowest (Nuaillé, France). 4-(2-hydroxyethyl)-1-
piperazine-ethanesulfonic acid (HEPES) was purchased from Alfa Aesar 
(Massachusetts, USA). While streptomycin/penicillin was purchased 
from Caisson Labs (Utah, USA). 
Cell Titer 96 Non-Radioactive Cell Proliferation Assay kit was 
purchased from Promega (Wisconsin, USA). Mouse Casp3 (caspase-
3) enzyme-linked immunosorbent assay (ELISA) kit was purchased 
from MyBioSource (San Diego, USA). For western blotting, Mini-
PROTEAN TGX Precast Gels, Clarity Western ECL Substrate, 10x 
Tris/Glycine/SDS (TGS) buffer and 2x Laemmle were all obtained 
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from Biorad (California, USA). Gang-Nam prestained protein ladder 
was provided from iNtRON Biotechnology (Gyeonggi, South Korea). 
Tris Base, 2-mercaptoethanol and Tween 20 were obtained from 
Santa Cruz Biotechnology (Texas, USA) while methanol was supplied 
from Tedia company (Ohio, USA). Non-fat milk was purchased from 
Laita Diary Company (Brest, France). Nitrocellulose transfer 
membrane, Anti-Bax antibody and Goat Anti-Rabbit IGg HandL-HRP 
were obtained from Abcam (Cambridge, UK). 
Preparation of buffers and culture medium 
All perfusion buffers were freshly prepared using sterile techniques 
in a sterile class 2 biosafety cabinet (Topair systems, New York, 
USA), according to Al Shaker et al. (8). Perfusion buffer I was 
prepared by the addition of 0.5 mmol EDTA, 25 mmol HEPES and 0.5 
mmol Tris base to HBBS without Ca2+and Mg2+. Perfusion buffer II 
was prepared by adding 25 mmol HEPES and 0.5 mmol Tris base to 
HBSS with Ca2+and Mg2+. Perfusion buffer II with collagenase II was 
prepared by dissolving 1000 U/ml collagenase II in perfusion buffer 
II. Buffers were kept warm at 37 °C in a water bath and used within 
30 min from preparation. 
Plating medium was prepared by the addition of pre-warmed (37 
°C) 10% FBS, 100 U/ml penicillin, 100 mg/ml of streptomycin and 
10 mmol HEPES buffer to DMEM medium. Liver collection medium 
was prepared by suspending 25 mmol HEPES in cold DMEM. 
Animal handling 
The study protocol was reviewed by the Scientific Committee of the 
Department of Pharmacology and Biomedical Sciences and approved 
by the Scientific Ethical Committee of the Faculty of Pharmacy and 
Medical Sciences, University of Petra, Amman, Jordan (Approval 
number: 5-2016/2017). Adult male BALB/c mice with an average 
weight range of 22±3 g were housed at the Animal House of the 
University of Petra. Mice were kept in air-conditioned environment 
under controlled temperatures (22-24 °C), humidity (55-65%), and 
photoperiod cycles (12 hr light/12 hr dark). All experiments were 
achieved in accordance with University of Petra Institutional 
Guidelines on Animal Use which adopt the guidelines of the Federation 
of European Laboratory Animal Science Association (FELASA). 
Mouse liver cannulation and perfusion 
An adult male BALB/c mouse was anaesthetized by isoflurane and 
the liver was cannulated surgically through the portal vein as 
described by Al Shaker et al. (9); with few modifications where the 
pre-warmed perfusion buffer I was infused for approximately 20 
min at a flow rate of 3 ml/min until the liver had blanched to a light-
brown colour. The perfusion was later switched to perfusion buffer 
II containing collagenase II at a flow rate of 4 ml/min for 15 min. The 
liver was then dissected and soaked in a cooled liver collection 
medium in order to be transferred to the cell culture hood. 
Culture of primary mouse hepatocytes 
Hepatocytes were cultured in a 96-well plate and allowed to recover 
and grow in a humidified sterile CO2 incubator overnight prior the 
day of experimentation. After 16 h of incubation, the 96-well plate 
was divided into 9 groups. Group 1 as blank (media only), group 2 as 
a negative control (untreated healthy cells), group 3 Vit C 0.5 mmol, 
and groups 4, 5, and 6 treated with APAP 2.5, 5 and 10 mmol 
respectively. Groups 7, 8, 9 were pretreated with 0.5 mmol Vit C for 
4 h prior the addition of APAP at concentrations of 2.5, 5, and 10 
mmol, respectively. Treatment of hepatocytes and further 
mentioned assays were determined within the first 24 h from 
plating to assure minimal decline of CYP450 activity. 
Determination of mitochondrial electron transport capacity in 
isolated hepatocytes 
Apoptotic bodies are intact cells and maintain viable mitochondria, 
which provides cells with the needed ATP for energy-dependent cell 
death namely, apoptosis [11]; therefore, MTT assay was approached 
for that detection [12, 13]. Cultured and treated primary 
hepatocytes were subject to mitochondrial electron transport 
capacity determinations assessed by conducting an MTT assay using 
CellTiter 96 Non-Radioactive Cell Proliferation Assay kit, as 
instructed by the manufacturer (Promega, Wisconsin, USA). Optical 
density (OD) measurements were performed using Promega’s 
Glomax multi detection system (Wisconsin, USA). 
Annexin V/Propidium Iodide double staining 
Freshly isolated mouse hepatocytes were prepared as described 
earlier and incubated with APAP (10 mmol), Vit C (0.5 mmol), a 
combination of both APAP and Vit C for 3 h in a humidified CO2 
incubator under 37˚C. Following treatment, hepatocytes were 
resuspended in binding buffer, Annexin V and Propidium Iodide (PI) 
dye solutions. After 5 min of incubation in the dark, samples were 
investigated under fluorescence microscopy using fluorescence 
green and Texas red filters as per the manufacturer’s instructions 
(Abcam, Cambridge, UK). 
Caspase-3 concentration assay 
Caspase-3 concentrations were determined in cell lysate samples of 
cultured primary mouse hepatocyte using Mouse Casp3 (Caspase-3) 
ELISA kit (MyBioSource, San Diego, USA). Collection of cell lysates 
was proceeded by the addition of 0.25% Trypsin to the treated 
hepatocytes cell pellets with further sonication for 10 seconds using 
Qsonica probe sonicator (Newtown, CT. USA), followed by 
centrifugation at 1500 rpm for 10 min at 4 °C. The lysed supernatant 
was collected and tested immediately according to the 
manufacturer’s protocol. Optical density (OD) was read at 450 nm 
using an ELISA reader (Promega’s Glomax multi detection system, 
Wisconsin, USA). 
In vivo immunodetection of bax by western blot 
BALB/c mice were randomized into 4 groups (n=8 per group) and 
acclimatized for ten days before in vivo experiment. Mice were 
treated as following; group 1 served as a control, group 2 
administered APAP (700 mg/kg) suspended in 0.5% CMC solution, 
group 3 received Vit C (100 mg/kg) [14], while group 4 was 
pretreated with Vit C followed by APAP. All mice received either a 
daily single oral dose of 0.5% CMC or Vit C dissolved in CMC (100 
mg/kg) for three days prior APAP administration. Mice were fasted 
overnight with free access to water, and on the fourth-day groups 2 
and 4 received APAP (700 mg/kg) concomitantly with their 
corresponding treatments. Six hours post-APAP administration, 
blood was withdrawn from the orbital sinus under anaesthesia and 
serum was separated and stored at-20˚C for further analysis. Mice 
were euthanized by cervical dislocation after blood sampling. 
Semi-quantitative determinations of Bax levels were performed by 
western blot analysis according to standard protocols. Briefly, 
previously stored serum samples obtained from BALB/c mice were 
mixed with loading dye buffer and heated for 10 min at 80˚C in a 
mini heating dry bath (Major science, California, USA). Samples and a 
reference protein ladder were loaded on precast denaturing 10% 
SDS-PAGE gels with a final protein concentration of 10 μl/ml and 
run in Biorad Mini-PROTEAN Tetra System (California, USA) under 
standard running conditions. After electrophoresis, the proteins 
were blotted on nitrocellulose transfer membrane using wet buffer 
method. Blots were pre-blocked with 5% non-fat milk in Tris-
Tween-Buffer-Saline (TTBS) and probed with primary antibody Bax 
in milk at a 1:1000 ratio and secondary antibody anti-bax 
peroxidase-conjugated in milk (ratio of 1:10000) Blotted 
membranes were exposed to enhanced chemiluminescence (ECL) 
substrate, it was visualized on LI-COR C-DiGit Chemiluminescence 
Western Blot Scanner (LI-COR Biotechnology, NE, USA). 
Statistical analysis 
One-way analysis of variance (ANOVA) was performed to detect 
statistical significance between tested groups using SPSS software, 
version 22 (IBM Corporation, NY, USA). Values with p-value less 
than 0.05 were considered significant. Values are presented as 
mean±standard error of the mean (SEM).  
RESULTS AND DISCUSSION 
In the presented work, mice were selected as the animal model of 
choice to reveal the mechanism by which APAP induces its 
hepatotoxicity. Mice were previously found more sensitive to APAP 
toxicity than rats, accounted to alterations in APAP metabolism and 
protein binding, in addition to differences in mitochondrial 
dysfunction and oxidative stress between species 
it has been reported that APAP is capable of inducing hepatotoxicity 
in rats in a similar manner to that induced in mice when a thr
higher dose is employed [17, 18]. 
APAP Induction of mitochondrial-mediated hepatotoxicity
A dose-dependent increase in mitochondrial electron transport 
capacity was noted in APAP-treated hepatocytes as illustrated in 
1. Incubating hepatocytes with 2.5 and 5 mmol
insignificant increase in the mitochondrial electron transport 
capacity in comparison to untreated cells (
significant amplification of mitochondrial electron transport 
capacity was observed in hepatocytes treated with 10
 
Fig. 1: Percentage of mitochondrial electron transport capacity of
over a period of 2 h, Each data point represents the mean
electron transport capacity of hepatocytes. *
The Impact of pretreating intoxicated hepatocytes 
As illustrated in fig. 2, the mitochondrial electron transport capacity in 
hepatocytes solely treated with Vit C was not changed (
However, pretreating hepatocytes with Vit C prior to APAP 
intoxication reduced the APAP-induced dose-dependent induction of 
mitochondrial electron transport capacity. Such effect was found 
significant at the dose of 10 mmol APAP (p<0.05). Nevertheless, such 
reduction in activity was not detected in isolated hepatocytes treated 
with lower doses of APAP (p>0.05). It has been reported that Vit C 
could ameliorates the hepatotoxic effects of high doses of APAP on 
rodents through normalizing GSH levels, superoxide dismutase (
 
Fig. 2: The hepatoprotection produced by Vit C (0.5
The data shows that Vit C significantly reduced APAP
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 APAP caused an 
p>0.05). However, a 
 mmol APAP 
therefore, this dose was used in the subsequent studies (
The capability of APAP in inducing 
capacity in a dose-dependent manner. A significant increase in 
mitochondrial electron transport capacity 
isolated hepatocytes were challenged with 10
to lower concentrations (fig
pathway has been considered as a vital m
survival [19], as it initiates the production of pro
in response to the induced insult, activating
apoptosis [20]. Despite to CYP450 enzyme activation, which is a 
potential source of ROS and oxidative stress, the mitochondria stays 
the major source of ROS formation after toxic stimuli, in addition, its 
abnormal metabolic activity in apoptosis inc
production [21]. Furthermore, 
ATP-dependent cell death, including apoptosis 
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±SEM (n=8 wells). 10 mmol APAP had significantly increased the mitochondrial 
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and malondialdehyde (MDA) [24
property by acting as an important free radical scavenger in the 
extracellular fluids, Vit C has been reported to inhibit the ability of ROS 
from binding to the mitochondrial membr
disruption [27,28]. Thereafter, the antioxidant Vit C was selected to 
inhibit the cytotoxic effects of APAP and test its influence on the insult 
in vivo and in vitro. Vit C was capable of inhibiting the cellular insult 
caused by APAP. The presented data revealed that pretreatment with 
antioxidant Vit C effectively lowered APAP
mitochondrial electron transport capacity. These results are in 
agreement with other studies which showed th
be ameliorated by hepatoprotective scavenging effect
 
 mmol) on cells treated with different doses of APAP (2.5
-induced increase in cell mitochondrial electron transport capacity in 10




mitochondrial electron transport 
was indicated when 
 mmol APAP compared 
. 1). The mitochondrial apoptotic 
ean of initiating cell 
-apoptotic proteins 
 caspase activity and 
reased NAPDH oxidase 
mitochondrial activity is necessary in 
[22, 23]. 
(2.5, 5 and 10 mmol) 
–26]. In addition to its antioxidative 
ane and limiting its 
-induced escalation in 
at APAP toxicity could 
s [24, 29, 31]. 
 mmol, 5 mmol and 10 mmol). 
 mmol 
Induction of apoptosis in hepatocytes 
Untreated hepatocytes did not show any noticeable binding to 
Annexin V or PI. On the other hand, Annexin
representing apoptotic cells, were observed after APAP treatment as 
shown in table I and fig. 3. However, fewer cells were seen positiv
to both Annexin V and PI, indicating an intermediate or late stages of 
apoptosis or were undergoing subsequent secondary necrosis. 
Isolated primary hepatocytes incubated with Vit C prior to APAP 
presented the absence of necrotic cells and a significant d
apoptotic bodies. Annexin staining of APAP
suggested that the major mode of cell death post APAP cellular 
toxicity is apoptosis rather than necrosis (fig. 3). This result agrees 
 
Fig. 3: Representative images of isolated primary mouse hepatocyte stained with Annexin V and PI. (A) Untreated cells visualized on 
normal light bright field; (B) Untreated hepatocytes visualized on fluorescent Green Filte
showing normal intensity of Annexin V stainin
staining; (E) Vit C-APAP treated hepatocytes (Green Filter) indicating reduced i
treated hepatocytes visualized on Texas Red Filter. All images were cap
 




APAP (10 mmol) 
Vit C–APAP (10 mmol)  
Apoptotic cells take in Annexin V stain; necrotic cells take in Annexin
100% of hepatocytes seen under fluorescent microscopy
 
Activation of caspase-3 in hepatocytes 
The results demonstrate that hepatocytes treated with 10
APAP exhibited high caspase-3 concentrations that were 
significantly decreased when hepatocytes were pretreated with 0.5
mmol Vit C prior to APAP treatment. Vit C treatment significantly 
suppressed caspase-3 concentration in comparison to control 
hepatocytes. However, all three groups presented caspase
activities below levels of the untreated hepatocytes, as shown in 
4. However, incubating the cells with Vit C alone or prior to APAP 
intoxication highly reduced caspase-3 concentration in the cells, 
leaving the impact of Vit C to greater importance in caspase
dependent studies. In addition, Vit C remarkably decreased caspase
3 activity in APAP treated cells. The major two key caspase cascades 
are caspase-9/-3 and caspase-8/-3 cascades. The activation o
caspase-9 and-8 cascades yields to the expression of executioner 
caspase-3; however, caspase-9 is associated with increased 
mitochondrial electron transport capacity due to the triggering of its 
dysfunction unlike caspase-8, which is associated with dea
Qinna et al. 





with other published reports that demonstrated 
apoptosis in more than 60% of cells exposed to APAP 
observation of some necrotic cells agrees with a previously 
published study that mentioned the switch in cell death to necrosis 
at a dose of 10 mmol APAP and above 
cellular decline is initiated through apoptosis and further 
progression is dose and time-
that Vit C defeats ROS generation that is required for phys
caspase-dependent apoptosis thereby reduci
damage [33]. The current study showed that Vit C protected the 
cellular architecture of tested hepatocytes, as observations shifted 
towards a reduction in Annexin V
APAP-treated cells. 
r; (C) Cells treated with Vit C (Green Filter) 
g; (D) APAP treated hepatocytes (Green Filter) showing 
ntensity compared to APAP alon
tured as original objective 40x
tocytes treated with Vit C or APAP with 

















receptor signal transduction [34]
that the addition of APAP to isolated lysed mouse hepatocytes did 
not trigger the increase in caspase
Modulation of bax protein serum content by vitamin C
As presented in fig. 5, and compared to the control group, the 
serum Bax level was considerably increased in mice intoxicated 
with 700 mg/kg APAP. However, such detection was reversed in 
animals pretreated with 100 mg/kg Vit C prior to APAP 
administration. Bax is a key member of the Bcl
which plays a leading role in the mitochondrial cell death pathway, 
in addition to maintaining the mitochondrial membrane integrity. 
Thus, inhibiting the release of the apoptogenic cytochrome c 
this study, western blot analysis indicated a trendlike increase in 
Bax levels in APAP-treated mice. T
studies that reported up to 4
comparison to untreated counterparts as early as 1 hour after 
APAP treatment, with a further increase during the next several 
11, 47-52 
50 
the occurrence of 
[22,32]. The 
[3], thus, proving that the 
dependent. It was recently reported 
iological 
ng the possible cellular 
+ve/PI–ve cells when compared to 
 
the 
the high intensity of Annexin V 







-40%; (+++) 40-60%; (++++) 60-
. In the current study, it was found 
-3 cellular content (fig. 4). 
 
-2 protein family, 
[5]. In 
hat, comes in line with several 
-fold increase in bax levels in 
hours [35–37]. The pre-treatment with Vit C attenuated APAP
induced increases of Bax serum levels and that comes in line with 
the literature, as hepatocytes pretreated with antioxidants prior to 
 
Fig. 4: Caspase-3 concentration of isolated mouse hepatocytes as determined by ELISA. Cells were either untreated, treated with 0.5
Vit C only, treated with 10 mmol APAP alone, or treated with 10
as units for caspase-3 activity, and represent means
 
Fig. 5: Serum bax levels determined by Western Blotting in APAP
either untreated, treated with 700 mg/kg APAP alone or 100 mg/kg Vit C, and treated with 700 mg/kg APAP after pre
 
CONCLUSION 
Despite the knowledge provided in the literature about APAP and its 
toxicity, a mechanistic approach is still warranted to understand the 
influence of APAP on death pathways, cell survival and liver integrity. 
This study confirms the development of hepatoc
after a high dose of APAP through the ability of APAP in triggering the 
mitochondrial electron transport capacity of hepatocytes. Apoptosis 
was found to be the initial cause of the hepatic injury induced by APAP 
as evident by the morphological evaluation of the APAP
These findings were supported by caspase-3 enzyme activity elevation 
in APAP-treated cells, and increased Bax protein 
detected in serum of APAP-intoxicated mice. When mice were 
pretreated or the isolated hepatocytes were pre
reduced Bax serum levels and cellular caspase 3 concentrations were 
evident, respectively. Such actions might suggest the strong capability 
of Vit C in preventing intoxicated hepatocytes from entering the 
apoptotic stage. 
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